Building a smarter roadmap for precision therapeutics.
Location: United States
Employees: 11-50
Total raised: $124M
Investors 4
| Date | Name | Website |
| 17.04.2023 | a16z | a16z.com/ |
| 30.08.2022 | MBC BioLab... | mbcbiolabs... |
| - | Catalio Ca... | cataliocap... |
| 25.08.2025 | Hawktail M... | hawktail.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.10.2025 | Series B | $67M | - |
| 21.07.2022 | Series A | $57M | Wing Ventu... |
Mentions in press and media 11
| Date | Title | Description |
| 23.07.2026 | Samsung Biologics Reports Second Quarter 2026 Financial Results | Recorded Q2'26 revenue of KRW 1,321 billion and operating profit of KRW 586 billion Delivered stable business performance through continued disciplined execution Expanded global presence while advancing innovation and future growth initiati... |
| 08.05.2026 | Cartography Biosciences: Strategic Investment From Samsung Ventures To Advance Oncology Pipeline | Cartography Biosciences and Samsung Ventures announced a strategic investment designed to support the advancement of Cartography’s oncology pipeline and the expansion of its proprietary drug discovery platform. The investment was made throu... |
| 07.05.2026 | LTZ Therapeutics Raises $38M in Funding | LTZ Therapeutics, a Redwood City, CA- and Shenzhen, China-based clinical-stage, immunotherapy-focused biotechnology company, raised $38M in funding. The round was led by GL Ventures, with participation from a sovereign wealth fund and exist... |
| 07.05.2026 | Cartography Biosciences Receives Investment From Samsung Ventures | Cartography Biosciences, a San Francisco, CA-based developer of antibody-based oncology therapies, received an investment from Samsung Ventures. The amount of the deal was not disclosed. The company intends to use the funds to support the a... |
| 06.10.2025 | LOTTE Holdings Healthcare and Biopharmaceutical CVC Announces Investment in Cartography Biosciences | Cartography Biosciences TOKYO, JAPAN, October 6, 2025 /EINPresswire.com/ -- LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in Cartography Biosciences, Inc. (hereinafter... |
| 02.10.2025 | Cartography Biosciences Inks $67M Series B | SAN FRANCISCO, CA, Cartography Biosciences today announced the close of a $67 million Series B financing. >> Click here for more funding data on Cartography Biosciences >> To export Cartography Biosciences funding data to PDF a... |
| 02.10.2025 | Cartography Raises $67M in Series B Funding | Cartograpgy, a San Francisco, CA-based oncology company advancing a pipeline of T-cell engaging bispecific and multi-specific antibody therapeutics that target novel and highly specific tumor antigens, raised $67M in Series B funding. The r... |
| 21.07.2022 | A first-time VC raised $2 million in 2 months to invest in women after Roe was overturned | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Erika Lucas wasn’t planning on launching a venture fund two months ago. Lucas, who runs mentorshi... |
| 20.07.2022 | Cartography Biosciences Launches With USD57M in Series A Funding | Cartography Biosciences, a Foster City, CA-based precision medicine company creating therapeutics guided by comprehensive antigen atlas for immuno-oncology targets, launched with $57 million in initial funding. 8VC led the Series A financin... |
| 19.07.2022 | Cartography Biosciences gets on the map with $57M and an itinerary for next-gen cancer therapies | Cartography Biosciences is putting its name on the map, exiting stealth mode with $57 million for an antigen atlas designed to direct scientists to more precise and effective immunotherapies. The series A financing round was led by 8VC, an ... |
Show more